What is the Glycosidases market size?

The Glycosidases market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Glycosidases market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Glycosidases market?

Increasing demand for glycosidases in pharmaceutical and biotechnology applications drives the market.

What are the challenges faced by the Glycosidases market?

High production costs and limited availability of raw materials are major challenges.

Which regions are the leaders in the Glycosidases market?

North America and Europe are the leading regions in the Glycosidases market.

Who are the top companies in the Glycosidases market?

Top companies include Novozymes, DuPont, and BASF, among others.

What are the future opportunities in the Glycosidases market?

Emerging applications in biofuels and animal feed offer future opportunities.

How does technology impact the Glycosidases market?

Advances in enzyme technology and genetic engineering improve production efficiency.

What is the regulatory landscape of the Glycosidases market?

Stringent regulations and safety standards govern the use of glycosidases in various applications.

What is the future outlook for the Glycosidases market?

The market is expected to experience steady growth driven by increasing demand.

Glycosidases Market Intelligence Report 2026 — Updated June 2026

Glycosidases by Type (Endoglycosidase, Exoglycosidase, World Glycosidases Production), by Application (Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Others, World Glycosidases Production), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Glycosidases Market Overview

The Glycosidases market refers to the global industry involved in the research, development, and commercialization of glycosidase enzymes, which are used in various applications such as pharmaceuticals, food and beverages, and biofuels. As the Glycosidases market size is expected to witness significant growth, driven by increasing demand for these enzymes in various end-use industries, the growth outlook and market forecast are crucial for stakeholders to understand the industry expansion. The scope of this market encompasses various types of glycosidases, including alpha-galactosidase, beta-glucosidase, and alpha-amylase, among others.

Loading chart…

The current Glycosidases market size is approximately $1.3 billion, and it is expected to grow at a CAGR of around 7-8% during the forecast period, driven by macro drivers such as increasing demand for biofuels, growing awareness about the benefits of glycosidases in pharmaceutical applications, and rising demand for food and beverages with low sugar content. Key forces shaping the industry include technology shifts towards more efficient and cost-effective production methods, regulations related to the use of glycosidases in food and pharmaceutical applications, and competitive intensity among market players. The largest region for the Glycosidases market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing demand from countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent Technologies; New England Biolabs; Thermo Fisher Scientific; Merck Group; Takara Bio; Waters Corporation; Geno Technology; Sumitomo Bakelite; PerkinElmer; Cambridge Isotope Laboratories; FUJIFILM Wako Pure Chemical Corporation; S-BIO; Vaupell Holdings; RandD Systems; Bruker; Danaher; Shimadzu Analytical; RayBiotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Glycosidases market is poised for significant growth, driven by various factors that are shaping its dynamics. Understanding these market dynamics is crucial for stakeholders to navigate the complex landscape and capitalize on emerging opportunities.

Growth Drivers2 items

Advances in biotechnology and genomics are expanding the applications of Glycosidases, driving up demand and contributing to the growth forecast of the Glycosidases market size.

Increasing investments in research and development by pharmaceutical and biotechnology companies are leading to the discovery of new Glycosidases, further fueling the growth of the Glycosidases market.

Restraints2 items

Stringent regulatory requirements and high development costs are limiting the entry of new players into the Glycosidases market, potentially restraining its growth.

The complexity of Glycosidases production and purification processes is a significant challenge, affecting the overall efficiency and cost-effectiveness of these enzymes, and thus impacting the Glycosidases market size.

Opportunities2 items

The growing demand for personalized medicine and targeted therapies presents opportunities for the development of novel Glycosidases with specific substrate preferences, driving innovation in the Glycosidases market.

Emerging applications in diagnostics and biomarker discovery are expected to further expand the Glycosidases market, as these enzymes play a critical role in disease diagnosis and monitoring.

Challenges2 items

The global supply chain of Glycosidases is vulnerable to disruptions, which can impact the availability and pricing of these enzymes, affecting the growth forecast of the Glycosidases market.

Ensuring the stability and consistency of Glycosidases activity and specificity remains a significant challenge, particularly in large-scale industrial applications, and is crucial for the overall growth of the Glycosidases market size.

Market Segmentation

Loading chart…

The Type segment in the Glycosidases market refers to the various forms of glycosidases, including alpha-galactosidase, beta-galactosidase, alpha-glucosidase, and beta-glucosidase, among others. This segmentation is crucial in understanding the Glycosidases segmentation as it helps in identifying the specific type of enzyme that is in high demand, thereby contributing to the overall market size. Each type of glycosidase has its unique application and market share, making it essential to analyze this segment separately.

The Application segment in the Glycosidases market is further divided into pharmaceuticals, food and beverages, biofuels, and research and development, among others. This segmentation category plays a significant role in determining the market size of glycosidases as it highlights the various industries that utilize these enzymes. Understanding the application segment is vital in identifying the trends and opportunities in the Glycosidases market, ultimately contributing to the growth of the market. The application segment is a critical component of market taxonomy as it provides insights into the diverse uses of glycosidases.

Glycosidases Segmentation Breakdown9 items

Type

Endoglycosidase

Exoglycosidase

World Glycosidases Production

Application

Academic Research Institutes

Pharmaceutical And Biotechnology Companies

Others

World Glycosidases Production

Regional Insights

Loading chart…

The Glycosidases market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 35% of the market share, and the fastest-growing region, driven by increasing adoption of glycosidases in the pharmaceutical and biotechnology industries. Key drivers for Asia Pacific include government policies supporting research and development, significant investments in infrastructure, and a large demographics with a growing middle class.

In North America, key drivers include a mature ecosystem, high adoption rates of glycosidases in the pharmaceutical industry, and significant investments in research and development. Europe is driven by a strong infrastructure and a highly developed ecosystem, with a focus on sustainability and environmental concerns. Latin America and Middle East & Africa are driven by growing demographics and increasing adoption of glycosidases in the pharmaceutical and biotechnology industries.

Regional Forecast5 items

North America: 25% share, driven by a mature ecosystem and high adoption rates

Europe: 20% share, driven by a strong infrastructure and focus on sustainability

Asia Pacific: 35% share, driven by government policies, investments, and demographics

Latin America: 10% share, driven by growing demographics and increasing adoption

Middle East & Africa: 10% share, driven by growing demographics and increasing adoption

Competitive Landscape

The Glycosidases market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Glycosidases competitive landscape is characterized by high competition, with companies focusing on differentiation through innovation, quality, and customer service. Global players have a strong presence, while local companies focus on regional expansion and customization.

Companies in the Glycosidases market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and innovation.

Agilent Technologies: regional expansion

New England Biolabs: innovation pipeline

Thermo Fisher Scientific: vertical integration

Merck Group: premium pricing

Takara Bio: OEM tie-ups

Waters Corporation: local manufacturing

Key Glycosidases Companies18 items

Agilent Technologies

New England Biolabs

Thermo Fisher Scientific

Merck Group

Takara Bio

Waters Corporation

Geno Technology

Sumitomo Bakelite

PerkinElmer

Cambridge Isotope Laboratories

FUJIFILM Wako Pure Chemical Corporation

S-BIO

Vaupell Holdings

RandD Systems

Bruker

Danaher

Shimadzu Analytical

RayBiotech

Market Ecosystem

The Glycosidases ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three primary tiers: upstream, midstream, and downstream, with value created and captured through the interactions between technology providers, integrators, channels, and end users. The Glycosidases ecosystem is characterized by a delicate balance of power, with different stakeholders exerting influence over the creation, distribution, and adoption of glycosidases.

Raw material suppliers — providing enzyme substrates

Technology providers — developing glycosidase enzymes

OEMs / manufacturers — producing glycosidase-based products

System integrators / EPCs — integrating glycosidases into larger systems

Distributors / channel partners — facilitating glycosidase distribution

Regulators/standards bodies — establishing glycosidase standards and guidelines

End users / buyers — utilizing glycosidases in various applications

As value flows through the Glycosidases ecosystem, control points emerge, with regulators and standards bodies influencing adoption through approvals and guidelines. Dependency risks also arise, including input constraints and standards compliance, which can impact the entire value chain. Furthermore, switching costs, partnerships, and interoperability requirements can create bottlenecks, while regional differences in regulations and standards can lead to variations in the ecosystem's structure and dynamics, highlighting the need for a thorough value chain analysis to navigate the complex Glycosidases ecosystem.

Recent Industry Insights

Recent developments in the Glycosidases market have been driven by strategic partnerships, mergers, and acquisitions. Over the last 12-18 months, key players have focused on expanding their product portfolios and technological capabilities. For instance, several companies have launched new enzymatic products with improved specificity and efficiency. Furthermore, regulatory changes have led to increased investment in research and development, driving Glycosidases industry trends. Shifts in consumer and enterprise trends have also spurred the adoption of glycosidases in various applications, including pharmaceuticals and biofuels. Additionally, funding rounds and expansions have enabled companies to scale up their production capacities and explore new markets.

Analyst Overview

The Glycosidases market outlook is promising, driven by increasing demand for novel therapeutics and diagnostics. Market attractiveness is high, with opportunities for growth in the pharmaceutical and biotechnology sectors. Competitive intensity is moderate, with key players investing in research and development to stay ahead. The long-term outlook is favorable, with potential applications in emerging fields such as personalized medicine and gene editing.

The innovation landscape is dynamic, with ongoing advancements in enzyme engineering and biocatalysis. Demand-supply balance is expected to be stable, with manufacturers expanding production capacity to meet growing demand. However, key risk factors include regulatory uncertainties and supply chain disruptions, which could impact market growth. Overall, the Glycosidases market is poised for significant expansion, driven by cutting-edge research and growing industry demand.

12 items

1. Executive Summary

2. Glycosidases Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Glycosidases Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Glycosidases Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Glycosidases Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Glycosidases Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Glycosidases Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Glycosidases Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Glycosidases Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Glycosidases Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Glycosidases Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Glycosidases Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Glycosidases Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Glycosidases Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Glycosidases Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Glycosidases Market Competition by Key Manufacturers

9.1. Global Glycosidases Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Glycosidases: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Agilent Technologies

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. New England Biolabs

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Thermo Fisher Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Merck Group

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Takara Bio

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Waters Corporation

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Geno Technology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Sumitomo Bakelite

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. PerkinElmer

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Cambridge Isotope Laboratories

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. FUJIFILM Wako Pure Chemical Corporation

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. S-BIO

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Vaupell Holdings

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. RandD Systems

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Bruker

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Danaher

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Shimadzu Analytical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. RayBiotech

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Glycosidases Market

Figure 4: Global Glycosidases Market: Drivers

Figure 5: Global Glycosidases Market: Challenges

Figure 6: Global Glycosidases Market: Trends

Figure 7: Global Glycosidases Market: Opportunity

Figure 8: Global Glycosidases Market: Restraint

Figure 9: Global Glycosidases Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Glycosidases Market Value (USD Million) By Region

Figure 19: Global Glycosidases Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Glycosidases Market Value (USD Million) By Region

Figure 27: Global Glycosidases Market Share (%) By: Regions (2032)

Figure 28: Global Glycosidases Market Volume (K) By Region

Figure 29: Global Glycosidases Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Glycosidases Market Value (USD Million) By Region

Figure 37: Global Glycosidases Market Share (%) By: Regions (2032)

Figure 38: Global Glycosidases Market Volume (K) By Region

Figure 39: Global Glycosidases Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Glycosidases Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Glycosidases Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Glycosidases Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Glycosidases Market Value (USD Million) By Region

Table 14: Global Glycosidases Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Glycosidases Market Volume (K) By Region

Table 31: Global Glycosidases Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Glycosidases Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Glycosidases Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Glycosidases Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Agilent Technologies Basic Information And Sales Area

Table 52: Agilent Technologies. Products Portfolio

Table 53: New England Biolabs Basic Information And Sales Area

Table 54: New England Biolabs. Products Portfolio

Table 55: Thermo Fisher Scientific Basic Information And Sales Area

Table 56: Thermo Fisher Scientific. Products Portfolio

Table 57: Merck Group Basic Information And Sales Area

Table 58: Merck Group. Products Portfolio

Table 59: Takara Bio Basic Information And Sales Area

Table 60: Takara Bio. Products Portfolio

Table 61: Waters Corporation Basic Information And Sales Area

Table 62: Waters Corporation. Products Portfolio

Table 63: Geno Technology Basic Information And Sales Area

Table 64: Geno Technology. Products Portfolio

Table 65: Sumitomo Bakelite Basic Information And Sales Area

Table 66: Sumitomo Bakelite. Products Portfolio

Table 67: PerkinElmer Basic Information And Sales Area

Table 68: PerkinElmer. Products Portfolio

Table 69: Cambridge Isotope Laboratories Basic Information And Sales Area

Table 70: Cambridge Isotope Laboratories. Products Portfolio

Table 71: FUJIFILM Wako Pure Chemical Corporation Basic Information And Sales Area

Table 72: FUJIFILM Wako Pure Chemical Corporation. Products Portfolio

Table 73: S-BIO Basic Information And Sales Area

Table 74: S-BIO. Products Portfolio

Table 75: Vaupell Holdings Basic Information And Sales Area

Table 76: Vaupell Holdings. Products Portfolio

Table 77: RandD Systems Basic Information And Sales Area

Table 78: RandD Systems. Products Portfolio

Table 79: Bruker Basic Information And Sales Area

Table 80: Bruker. Products Portfolio

Table 81: Danaher Basic Information And Sales Area

Table 82: Danaher. Products Portfolio

Table 83: Shimadzu Analytical Basic Information And Sales Area

Table 84: Shimadzu Analytical. Products Portfolio

Table 85: RayBiotech Basic Information And Sales Area

Table 86: RayBiotech. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Type

Table 88: Global Market Share (%) By Type (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Type

Table 92: Global Market Share (%) By Type (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Glycosidases Market Value (USD Million) By Region

Table 96: Global Glycosidases Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Type

Table 99: North America Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Type

Table 102: Europe Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Type

Table 108: South America Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 112: Global Glycosidases Market Volume (K) By Region

Table 113: Global Glycosidases Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Type

Table 116: North America Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Type

Table 119: Europe Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Type

Table 125: South America Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Glycosidases Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Agilent Technologies; New England Biolabs; Thermo Fisher Scientific; Merck Group; Takara Bio; Waters Corporation; Geno Technology; Sumitomo Bakelite; PerkinElmer; Cambridge Isotope Laboratories; FUJIFILM Wako Pure Chemical Corporation; S-BIO; Vaupell Holdings; RandD Systems; Bruker; Danaher; Shimadzu Analytical; RayBiotech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in biotechnology and genomics are expanding the applications of Glycosidases, driving up demand and contributing to the growth forecast of the Glycosidases market size.

Restraints2 items

Stringent regulatory requirements and high development costs are limiting the entry of new players into the Glycosidases market, potentially restraining its growth.

Opportunities2 items

Emerging applications in diagnostics and biomarker discovery are expected to further expand the Glycosidases market, as these enzymes play a critical role in disease diagnosis and monitoring.

Challenges2 items

The global supply chain of Glycosidases is vulnerable to disruptions, which can impact the availability and pricing of these enzymes, affecting the growth forecast of the Glycosidases market.

Market Segmentation

Loading chart…

Glycosidases Segmentation Breakdown9 items

Type

Endoglycosidase

Exoglycosidase

World Glycosidases Production

Application

Academic Research Institutes

Pharmaceutical And Biotechnology Companies

Others

World Glycosidases Production

Regional Insights

Loading chart…

Regional Forecast5 items

North America: 25% share, driven by a mature ecosystem and high adoption rates

Europe: 20% share, driven by a strong infrastructure and focus on sustainability

Asia Pacific: 35% share, driven by government policies, investments, and demographics

Latin America: 10% share, driven by growing demographics and increasing adoption

Middle East & Africa: 10% share, driven by growing demographics and increasing adoption

Competitive Landscape

Agilent Technologies: regional expansion

New England Biolabs: innovation pipeline

Thermo Fisher Scientific: vertical integration

Merck Group: premium pricing

Takara Bio: OEM tie-ups

Waters Corporation: local manufacturing

Key Glycosidases Companies18 items

Agilent Technologies

New England Biolabs

Thermo Fisher Scientific

Merck Group

Takara Bio

Waters Corporation

Geno Technology

Sumitomo Bakelite

PerkinElmer

Cambridge Isotope Laboratories

FUJIFILM Wako Pure Chemical Corporation

S-BIO

Vaupell Holdings

RandD Systems

Bruker

Danaher

Shimadzu Analytical

RayBiotech

Market Ecosystem

Raw material suppliers — providing enzyme substrates

Technology providers — developing glycosidase enzymes

OEMs / manufacturers — producing glycosidase-based products

System integrators / EPCs — integrating glycosidases into larger systems

Distributors / channel partners — facilitating glycosidase distribution

Regulators/standards bodies — establishing glycosidase standards and guidelines

End users / buyers — utilizing glycosidases in various applications

Recent Industry Insights

Analyst Overview

Table of Contents